Abstract

Stem cells undergo cellular division during their differentiation to produce daughter cells with a new cellular identity. However, the epigenetic events and molecular mechanisms occurring between consecutive cell divisions have been insufficiently studied due to technical limitations. Here, using the FUCCI reporter we developed a cell-cycle synchronised human pluripotent stem cell (hPSC) differentiation system for uncovering epigenome and transcriptome dynamics during the first two divisions leading to definitive endoderm. We observed that transcription of key differentiation markers occurs before cell division, while chromatin accessibility analyses revealed the early inhibition of alternative cell fates. We found that Activator protein-1 members controlled by p38/MAPK signalling are necessary for inducing endoderm while blocking cell fate shifting toward mesoderm, and that enhancers are rapidly established and decommissioned between different cell divisions. Our study has practical biomedical utility for producing hPSC-derived patient-specific cell types since p38/MAPK induction increased the differentiation efficiency of insulin-producing pancreatic beta-cells.

Many stem cells exhibit cell division coupled to differentiation, though the changes occurring between consecutive cell divisions have been difficult to study. Here they use synchronized hPSC culture to show that production of transcription factors and epigenetic changes are linked with cell division timing.

Details

Title
Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation
Author
Madrigal, Pedro 1   VIAFID ORCID Logo  ; Deng, Siwei 2   VIAFID ORCID Logo  ; Feng, Yuliang 2 ; Militi, Stefania 2 ; Goh, Kim Jee 3 ; Nibhani, Reshma 2   VIAFID ORCID Logo  ; Grandy, Rodrigo 4   VIAFID ORCID Logo  ; Osnato, Anna 4   VIAFID ORCID Logo  ; Ortmann, Daniel 4 ; Brown, Stephanie 4 ; Pauklin, Siim 2   VIAFID ORCID Logo 

 University of Cambridge, Department of Surgery, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); University of Cambridge, Wellcome – MRC Cambridge Stem Cell Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726) 
 University of Oxford, Headington, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Old Road, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Cambridge, Department of Surgery, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); The Francis Crick Institute, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) 
 University of Cambridge, Department of Surgery, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
Pages
405
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2768985486
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.